Cornelia de Lange syndrome (CdLS) is a dominantly inherited congenital malformation disorder, caused by mutations in the cohesinloading protein NIPBL 1,2 for nearly 60% of individuals with classical CdLS 3-5 , and by mutations in the core cohesin components SMC1A ( 5%) and SMC3 (,1%) for a smaller fraction of probands 6, 7 . In humans, the multisubunit complex cohesin is made up of SMC1, SMC3, RAD21 and a STAG protein. These form a ring structure that is proposed to encircle sister chromatids to mediate sister chromatid cohesion 8 and also has key roles in gene regulation 9 . SMC3 is acetylated during S-phase to establish cohesiveness of chromatin-loaded cohesin 10-13 , and in yeast, the class I histone deacetylase Hos1 deacetylates SMC3 during anaphase [14] [15] [16] . Here we identify HDAC8 as the vertebrate SMC3 deacetylase, as well as loss-of-function HDAC8 mutations in six CdLS probands. Loss of HDAC8 activity results in increased SMC3 acetylation and inefficient dissolution of the 'used' cohesin complex released from chromatin in both prophase and anaphase. SMC3 with retained acetylation is loaded onto chromatin, and chromatin immunoprecipitation sequencing analysis demonstrates decreased occupancy of cohesin localization sites that results in a consistent pattern of altered transcription seen in CdLS cell lines with either NIPBL or HDAC8 mutations.
Cornelia de Lange syndrome (CdLS) is a dominantly inherited congenital malformation disorder, caused by mutations in the cohesinloading protein NIPBL 1,2 for nearly 60% of individuals with classical CdLS [3] [4] [5] , and by mutations in the core cohesin components SMC1A ( 5%) and SMC3 (,1%) for a smaller fraction of probands 6, 7 . In humans, the multisubunit complex cohesin is made up of SMC1, SMC3, RAD21 and a STAG protein. These form a ring structure that is proposed to encircle sister chromatids to mediate sister chromatid cohesion 8 and also has key roles in gene regulation 9 . SMC3 is acetylated during S-phase to establish cohesiveness of chromatin-loaded cohesin [10] [11] [12] [13] , and in yeast, the class I histone deacetylase Hos1 deacetylates SMC3 during anaphase [14] [15] [16] . Here we identify HDAC8 as the vertebrate SMC3 deacetylase, as well as loss-of-function HDAC8 mutations in six CdLS probands. Loss of HDAC8 activity results in increased SMC3 acetylation and inefficient dissolution of the 'used' cohesin complex released from chromatin in both prophase and anaphase. SMC3 with retained acetylation is loaded onto chromatin, and chromatin immunoprecipitation sequencing analysis demonstrates decreased occupancy of cohesin localization sites that results in a consistent pattern of altered transcription seen in CdLS cell lines with either NIPBL or HDAC8 mutations.
Human SMC3 is acetylated by ESCO1 and ESCO2, homologues of yeast Eco1, and has been shown to be important for the establishment of sister chromatid cohesion 10, 11, 13, 17, 18 . Using a monoclonal antibody specific for acetylated SMC3 (SMC3-ac) 18 , we found that whereas total SMC3 levels remain stable throughout the cell cycle, SMC3-ac rapidly disappears during mitosis, suggesting coordinated deacetylation ( Supplementary Fig. 1 ).
We therefore used RNA interference (RNAi)-based screening of all known human histone deacetylases (HDACs) and sirtuins to identify HDAC8 as the vertebrate SMC3 deacetylase ( Supplementary Fig. 2 ). Loss of HDAC8 activity using either HDAC8 RNAi or the HDAC8specific inhibitor PCI-34051 (PCI; Fig. 1a , b) does not alter cell cycle progression, but clearly increases SMC3-ac in both soluble and chromatin fractions throughout the cell cycle (Fig. 1c, lanes 4 and 6,   Fig. 1e , lanes 18-22 and 29-33, and Supplementary Fig. 3d , lanes 22-28 and [36] [37] [38] [39] [40] [41] [42] . Nearly all HDAC8 is present in the soluble fraction in both asynchronous and synchronized cultures ( Fig. 1c, e ). These data indicate that HDAC8 is present and active throughout the cell cycle, and that soluble SMC3-ac is its deacetylation target, similar to Hos1 in yeast [14] [15] [16] . Notably, the increase of SMC3-ac in the soluble fraction in the absence of HDAC8 activity suggests that SMC3-ac dissociates from chromatin but fails to be deacetylated. In addition, we unexpectedly observed few sister chromatid cohesion defects with loss of HDAC8 activity alone ( Supplementary Fig. 4 ).
To understand the role of HDAC8 in genome-wide regulation of cohesin dynamics, we performed chromatin immunoprecipitation sequencing (ChIP-Seq) analysis of synchronized HeLa cells transfected with control or HDAC8 RNAi ( Fig. 2 ) and immunoprecipitated with either an anti-RAD21 antibody to detect total cohesin or an anti-SMC3-ac antibody. Although total cellular cohesin shows no decrease ( Supplementary Fig. 5a, b) , and there is a high degree of overlap between SMC3-ac, cohesin and CTCF 19 localization sites in treated and untreated cells, high read numbers and tight correlations between experimental replicates enabled us to identify a 17% loss of total cohesin localization peaks with reduced HDAC8 activity ( Fig. 2a-c and Supplementary Fig. 5d -h). Furthermore, despite using conditions that increase total SMC3-ac more than twofold ( Fig. 1e and Supplementary Fig. 3d ), we note a 16% loss of SMC3-ac localization sites with HDAC8 reduction ( Fig. 2a-d and Supplementary Fig. 5f , g). Finally, we found that in both control and HDAC8-depleted cells, SMC3-ac preferentially localizes to downstream regions of genes relative to the distribution of RAD21 (Fig. 2c, d and Supplementary  Fig. 5f , g). Together, this data demonstrates decreased occupancy of cohesin localization sites with the loss of HDAC8 activity, an observation similarly noted for NIPBL haploinsufficient CdLS cells 20 .
With the known role of cohesin regulation in CdLS and the observations that a reduction in either HDAC8 or NIPBL leads to decreased cohesin occupancy of localization sites, we proposed that HDAC8 mutations may cause CdLS. We screened this X-linked gene in 154 individuals with CdLS negative for mutations in NIPBL, SMC1A and SMC3, as well as RAD21 (also known as SSC1), STAG2, ESCO1, ESCO2 and MAU2 (also known as SCC4). We identified four de novo missense mutations and one de novo nonsense mutation in HDAC8 (Supplementary Table 1 and Fig. 3a ). In addition, one familial mutation (c.1001A.G; p.H334R) was identified in a boy, his mildly affected sister and his unaffected mother, in which the mutant allele was inactivated in her blood. This mutation was also one of the de novo mutations in an unrelated girl. None of the mutations was seen in 290 ethnically matched control chromosomes or in 629 individuals of the 1000 Genomes Project 21 . Despite the small numbers and the varied clinical features in females due to random X-chromosome inactivation, these children demonstrate growth, cognitive and facial features consistent with those caused by mutations in NIPBL ('classical' CdLS). Both expression studies ( Supplementary Fig. 6a ) and X-chromosome inactivation studies (data not shown) demonstrate complete skewing towards the normal allele in the blood of females with HDAC8 mutations, indicating strong selection against the mutation. This limited the number of cell lines available for subsequent studies. However, immunoblotting demonstrated minimal HDAC8 protein expression in lymphoblastoid cell lines (LCLs) from a hemizygous boy with a p.G320R mutation as well as the skin fibroblasts from a female lyonized to express a p.H180R mutant allele ( Fig. 3b ), indicating protein instability in each case. Consistent with this, assessment of SMC3-ac demonstrates increased levels in both the p.G320R LCLs and the p.H180R fibroblasts, whereas the total amount of SMC3 ( Fig. 3b ) and cell cycle distribution for the LCLs are unchanged ( Supplementary Fig. 6b ).
We expressed the HDAC8 missense mutations in Escherichia coli, purified and assayed each for deacetylase activity. These data ( Fig. 3c ) demonstrate that the p.H180R mutation severely abrogates HDAC8 deacetylase activity, and demonstrate significant activity losses for the p.G320R, p.T311M and p.H334R mutations, consistent with high conservation of each residue and position in the structure of HDAC8substrate complexes 22,23 ( Fig. 3d and Supplementary Fig. 6c-e ). Finally, purified wild-type, but not mutant HDAC8, can rescue the SMC3 overacetylation seen in HDAC8 mutant LCLs ( Supplementary  Fig. 6g , h).
We have previously demonstrated that mutations in NIPBL, the primary cause of CdLS, result in consistent, reproducible changes of genes expressed from LCLs derived from individuals with CdLS 20 . Using Nanostring multiplex expression analysis to avoid variation introduced by PCR or RNA amplification-based assessments and a previously validated 32-gene CdLS classifier set 20 , we compared the expression of LCLs from the male with the p.G320R mutation and from two girls (with the p.H180R and p.H334R mutations) who express only the normal allele in these cells, to 10 normal controls and 12 LCLs with loss of function NIPBL mutations. In this assay, the aggregate 32-gene LCL expression profile of the single male with an HDAC8 mutation strongly correlates with that seen in NIPBLmutant cell lines, whereas the profile for the two female lines, which express the wild-type allele, correlates with normal controls (Fig. 3e ). These data support the hypothesis that loss of HDAC8 activity results in widespread transcriptional dysregulation as seen in NIPBL-mutated CdLS cells. The loss of cohesin-binding sites in HDAC8 RNAidepleted HeLa cells and in NIPBL-mutant LCLs 20 was also noted in the p.G320R HDAC8-mutant LCLs and fibroblasts derived from the girl with the p.H180R mutation, in which small but consistent changes in transcriptional dysregulation were also noted (Supplementary Figs 6a, 7 and 8). Together, these data suggest that loss of HDAC8 activity leads to a common pathogenic mechanism for classical CdLS that converges on the reduction of bound cohesin complexes. with HDAC8 short interfering RNA (siRNA; lanes 1-4) or incubated with 25 mM PCI, the HDAC8-specific inhibitor (lanes 5-9), for the indicated times. Total cell lysates were prepared and analysed by immunoblotting using anti-SMC3-ac, SMC3 and HDAC8 antibodies. Numbers beneath SMC3-ac bands indicate quantification of SMC3-ac levels normalized to SMC3 levels and the 0 h time point. b, Acetylated SMC3 was prepared by co-immunoprecipitation with SMC1A from HeLa cell chromatin extracts. Immunoprecipitates (IP) were incubated with recombinant purified HDAC8 (rHDAC8) or mutant (mut) HDAC8 protein at 30 uC for 1 h and analysed by immunoblotting as in a.
Chr., chromatin; Sup., supernatant; WT, wild type. c, Unsynchronized HeLa cells transfected with HDAC8 siRNA for 48 h were fractionated into soluble and chromatin fractions and immunoblotted as in a. d, HeLa cells were synchronized by double thymidine arrest, and released in the presence or absence of 25 mM PCI for the indicated time and verified by FACS analysis for cell cycle progression. e, Cell extracts of the PCI-treated cells in d were fractionated into soluble and chromatin fractions and analysed by immunoblotting as in a. Histone H3 Ser 10 phosphorylation (H3S10P) is a marker of prophase and the onset of mitosis.
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To understand the endogenous effect of HDAC8 loss on cohesin further, we compared each cohesin subunit in chromatin-bound and unbound fractions in the LCLs with a hemizygous p.G320R mutation versus control LCLs, and unexpectedly noted accumulation of RAD21 fragments in HDAC8-mutant cells ( Supplementary Fig. 9a , lanes 2, 4 and 6). Using a RAD21 amino terminal-specific antibody, we verified accumulation of the RAD21 N-terminal separase cleavage fragment (RAD21-N) in mutant LCLs, HDAC8 RNAi-treated HeLa cells and HDAC8-mutated fibroblasts expressing catalytically inactive HDAC8 compared with wild-type HDAC8 ( Fig. 4 and Supplementary Fig. 9 ). The accumulation of this cleavage fragment in the chromatinbound fraction of HDAC8-mutant cells suggests that it may remain bound to the cohesin complex, so we assessed whether RAD21-N co-immunoprecipitates with other cohesin subunits. In HDAC8mutant cells, RAD21-N co-immunoprecipitates with SMC1A, SMC3, STAG1 and STAG2 (Fig. 4b) , strongly suggesting that without functional HDAC8, the cleaved N terminus of RAD21 remains attached to the cohesin complex, presumably via acetylated SMC3 (ref. 24). To confirm that clearance of cleaved RAD21 is dependent on HDAC8, we performed complementary analyses in synchronized HeLa cells with or without the HDAC8 inhibitor PCI (Fig. 4c, d) . These data demonstrate the appearance of the N-terminal and carboxy-terminal RAD21 fragments after entry into mitosis (marked by histone H3 Ser 10 phosphorylation; H3S10P) and activation of separase (Fig. 4d , lanes 9-12 and 21-24) as well as their persistence in both soluble and chromatin fractions (Fig. 4d, lanes 18-20) when most cells are in G1 phase (data not shown). By contrast, in untreated cells, these cleavage products are predominantly detected in the soluble fraction ( Fig. 4d , lanes 2-4), and largely disappear 3 h after release.
We also made several observations about HDAC8 activity in the prophase removal of cohesin 25, 26 . Loss of HDAC8 activity does not disrupt the prophase pathway of cohesin removal from chromatin, as demonstrated by a consistent reduction of chromatin-bound cohesin in the presence of metaphase inhibitors in either control or PCI-treated cells (Fig. 4d , lanes 13 and 17 versus 21-24). However, HDAC8 activity is necessary after prophase removal of cohesin, because in metaphase inhibitor-treated cells, soluble SMC3-ac is markedly increased in the presence of PCI (Fig. 4d, lanes 9-12) . Finally, with WAPAL depletion, which diminishes prophase removal of cohesin 18, 27, 28 , we noted that SMC3-ac is substantially increased ( Supplementary Fig. 9e ).
To test whether other cohesin-promoting proteins might remain associated with SMC3-ac in the absence of HDAC8 activity, we analysed HeLa and patient-derived cells, which also demonstrated increased retention of sororin (also known as CDCA5) 18 ,29 and RAD21-N, but not WAPAL, on soluble SMC3-ac ( Fig. 4e-g and Supplementary  Fig. 9d ). Taken together, these data strongly suggest that HDAC8 is necessary for the deacetylation of SMC3 after its removal from chromatin in both prophase and anaphase pathways to enable proper HDAC8 mutations labelled with corresponding mutation and sex. b, Western blotting of protein from LCLs and fibroblasts (Fib). Sex is indicated under controls (1, 2 and 3) or mutation designation. c, HDAC8 mutations disrupt deacetylase activity. Bar graphs demonstrate the effect of HDAC8 mutations on deacetylase specific activity (nmol substrate mmol enzyme 21 min 21 ). All assays were performed in triplicate. Error bars indicate standard deviation. Enzymatic activity for all mutations is significantly less than wild type (P , 0.05). d, Localization of HDAC8 mutations on the crystal structure (PDB accession code 3F06; ref. 23). Mutated residues are in red. e, The expression profile of HDAC8-mutant LCL is consistent with that seen in cell lines with NIPBL mutations. The summed standard deviations of gene expression compared with NIPBL mutant from control LCLs for 32 genes was determined for each sample. Box graphs demonstrate twenty-fifth, median and seventy-fifth percentiles of each group. Whiskers indicate minimum and maximum values. Note that for the HDAC8 male (p.G320R) the values are for biological replicate samples for a single cell line (denoted by asterisk). Unpaired two-tailed t-test significances are indicated.
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dissolution of pro-cohesive elements and allow for recycling of 'refreshed' cohesin for the next cell cycle ( Supplementary Fig. 10 ).
In summary, this work demonstrates that HDAC8 functions as a vertebrate SMC3 deacetylase to facilitate the renewal of cohesin after its removal from chromatin in prophase or anaphase, and that loss of HDAC8 activity results in decreased cohesin at localized sites to cause both cellular and clinical features of CdLS.
METHODS SUMMARY
Cell culture and synchronization, chromatin fractionation, purification of recombinant HDAC8 in baculovirus and E. coli, SMC3-ac deacetylation assays, RNA interference, immunofluorescence microscopy, human subjects, mutation screening, HDAC8 conservation analysis, crystal structure analysis, expression profiling, assessment of X-chromosome inactivation, chromatin immunoprecipitation, ChIP-Seq and RNA-Seq analyses are described in detail in the Methods. cells. PLoS Biol. 
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METHODS Antibodies and reagents. Primary antibodies used in this study are as previously described for RAD21 (hSCC1) 19 , SMC3-ac 18 and the RAD21 N terminus 30 . Antibodies used are as follows: SA1, SA2, SMC1A, HDAC6, HDAC10, SIRT4, SIRT5, SIRT7 were from Abcam; a-tubulin was from Sigma; histone H3(S10P), HDAC1, HDAC2, HDAC3, HDAC4, HDAC5, SIRT1, SIRT3, SIRT6, SIRT7 and MAD2L1 were from Cell Signaling Technology; HDAC7, HDAC11 and SIRT2 were from Millipore; and SMC3 was from Bethyl Laboratories. HDAC8 antibodies were purchased from Santa Cruz Biotechnology or derived as mouse monoclonal HDAC8 antibody raised against peptide CDAYLQHLQKVSQEGDDDHPDS. PCI-34051 was purchased from Sigma Chemical or synthesized by Synstar Japan. TSA, sodium butyrate and nicotinamide were from Wako Chemical. Suberoyl anilide bishydroxamide was from Toronto Research Chemicals. Nocodazole was from Calbiochem. Cell culture and synchronization. HeLa cells were cultured in DMEM (Invitrogen) supplemented with 0.2 mM L-glutamine, 100 U ml 21 penicillin, 100 mg ml 21 streptomycin and 10% FCS. LCLs were cultured in RPMI-1640 supplemented with 0.2 mM L-glutamine, 100 U ml 21 penicillin, 100 mg ml 21 streptomycin and 20% FCS. Fibroblasts were cultured in DMEM (Invitrogen) supplemented with 0.2 mM L-glutamine, 100 U ml 21 penicillin, 100 mg ml 21 streptomycin and 20% FCS. For cell cycle synchronization, HeLa cells were synchronized by double thymidine arrest (14-16 h in the presence of 2 mM thymidine, 8 h release, 16 h in the presence of 2 mM thymidine), and collected 6 h and 13 h after the second release for enrichment in the G2 and G1 phase, respectively. For enrichment in prometaphase of mitosis, nocodazole (330 nM) was added 8 h after release from the second thymidine block for 1 or 2 h, and cells were collected by shake off.
Protein extraction and immunoprecipitations. To obtain total cell extracts, cells were lysed with lysis buffer (20 mM Tris-HCl, pH 8.0, 100 mM NaCl, 10 mM KCl, 5 mM MgCl 2 , 0.2% NP-40, 10% glycerol, cOmplete protease inhibitor cocktail (Roche), and phosSTOP phosphatase inhibitor (Roche)) and DNA in the chromatin fraction was digested by the treatment of benzonase (Novagen). To obtain soluble cell extracts, the cells were lysed with lysis buffer containing 200 mM NaCl and centrifuged at 20,000g. Immunoprecipitations were performed using ProteinG magnetic beads conjugated with 5 mg antibodies and incubated with the cell extracts for 5 h at 4 uC. After washing with lysis buffer, the beads were suspended with SDS-PAGE sample buffer. RNA isolation and RT-PCR. Total RNA was isolated using Trizol (Invitrogen) and Nucleospin RNA II (Macherey-Nagel) following the manufacturer's instructions. Synthesis of complementary DNA was performed using SuperScript III first-strand synthesis system (Invitrogen). cDNA was amplified with KAPA SYBR fast qPCR kit (Kapa Biosystems) on an ABI 7500 real time PCR system (Applied Biosystems). Primer sequences were: HDAC9 forward, 59-CTTTGTC AGGTTCCTGCTGTTCTC-39, reverse, 59-TTCCTGTTTCCACAAGGCATTTC-39; ACTB forward, 59-TGGCACCCAGCACAATGAA-39, reverse, 59-CTAAGTCA TAGTCCGCCTAGAAGCA-39; and GAPDH forward, 59-GCACCGTCAAGG CTGAGAAC-39, reverse, 59-TGGTGAAGACGCCAGTGGA-39. Immunofluorescence microscopy. HeLa cells grown on 18-mm coverslips were fixed with 4% paraformaldehyde and permeabilized with PBS containing 0.5% Triton X-100 for 10 min. After blocking with goat serum in PBS, cells were incubated with primary antibodies for SMC3 or SMC3-ac. DNA was stained with 49,6-diamidino-2-phenylindole (DAPI). Chromatin fractionation. Performed as previously described 31 . Chromosome spreads. Cells treated with nocodazole (100 ng ml 21 ) were collected by mitotic shake off and hypotonically swollen in 40% PBS, 60% tap water for 5 min at room temperature. Cells were fixed with Carnoy's solution (methanol:acetic acid 5 3:1), dropped on glass slides and dried. Slides were stained with 5% Giemsa (Merck), and washed with water, air-dried and mounted with Entellan (Merck).
Purification of recombinant HDAC8 and SMC3-ac deacetylation assay. Fulllength cDNA of HDAC8 and the enzymatically dead HDAC8 mutant (D101A/ Y306F) 22 was subcloned into pFASTBacHT (Invitrogen). The Bac-to-Bac baculovirus expression system (Invitrogen) was used to produce recombinant virus according to the manufacturer's protocol. To express recombinant protein, Sf9 cells were infected with each baculovirus and incubated for 60 h at 27 uC. Total cell lysates were prepared using Laemmli SDS buffer and boiling for 5 min. For purification of HDAC8 protein, infected cells were lysed with buffer A (20 mM Tris-HCl, pH 7.5, 300 mM NaCl, 0.1% NP-40 and 10 mM 2-mercaptoethanol (2-ME)). After centrifugation at 3,000g the supernatants were incubated with Ni-NTA beads for 2 h at 4 uC. Expression analysis of CdLS 32-gene classifier. Lymphocyte culture and RNA extraction were performed as previously described 20 . Genes and Nanostring 35 probeset sequences are listed in Supplementary Table 3 . For each sample, 100 ng of RNA was analysed. Hybridizations were carried out by mixing 5 ml of each RNA sample (normalized to 20 ng ml 21 ) with 20 ml of NanoString nCounter Reporter probes and 5 ml of nCounter Capture probes (30 ml total reaction volume) and incubating the hybridizations at 65 uC for 18 h. After hybridization purification, NanoString reporter capture, stretching and imaging was performed as described 35 . To account for differences in assay efficiency the data was normalized to the sum of six positive internal control RNA spikes that ranged from 0.125 to128 fM. Internally normalized data were then subsequently normalized to the geometric mean of the ACTB and RPL19 spike-normalized counts. To assess reproducibility, Pearson's r correlation coefficient was calculated for three technical replicates (average r 5 0.99986) and 11 biological replicates (average r 5 0.99675).
To define a 'CdLS' profile, average expression and standard deviations were calculated for 32 genes using RNA from LCLs from 10 normal controls and 12 NIPBL truncating or nonsense mutations. For each patient gene expression assay, the number of deviations in expression from normal was determined and divided by the average NIPBL expression standard deviation. These products were then summed for each gene to give a score representing a sum of deviation from normal in a CdLS manner for all 32 genes tested for each patient. The data and calculation results for each step are in Supplementary Data File 1.
Recombinant HDAC8 protein expression and purification from E. coli. Identified human HDAC8 mutations were introduced into a previously described HDAC8-6His-pET20b construct 36 using a QuickChange site-directed mutagenesis kit (Agilent Genomics). Oligonucleotide sequences are available on request. HDAC8 was recombinantly expressed in BL21(DE3) E. coli cells and purified over Talon resin (Clontech) according to published procedures 23 , with minor modifications. In brief, 50 ml cultures (Luria-Bertani media supplemented with ampicillin (50 mg ml 21 )) were grown overnight and used to inoculate 1-l flasks (minimal media supplemented with ampicillin at 50 mg ml 21 ). Cells were grown at 37 uC until A 600 nm of ,0.5, at which point the cells were induced by the addition of isopropyl b-D-thiogalactopyranoside (0.4 mM final concentration) and ZnCl 2

